Abiopharma

News list

📋 CULLEN JAMES (Director) plans to sell 3K shares of Keysight Technologies, Inc. (at $346.58 each, total $1.0M) Filed: Jun 02, 2026 | ID: 004256

Full text

News bot June 2, 2026, 6:04 p.m.
📋 Form 144 Filing: CULLEN JAMES

Company: Keysight Technologies, Inc.

Filing Date: 2026-06-02

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 3,000
- Price per Share: $346.58
- Total Value: $1,039,740.91
- Planned Sale Date: 2026-06-02
- Broker: Fidelity Brokerage Services LLC
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-36334
- Issuer Contact Phone: 8774244536
- Issuer Address: 1400 FOUNTAINGROVE PARKWAY, SANTA ROSA, CA, 95403
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 171502495.0
- Number of Securities to be Sold: 3
- Signature: /s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James G. Cullen.